Skip to main content

Table 2 CT and pathological features according to EGFR mutation status

From: The radiological characteristics, tertiary lymphoid structures, and survival status associated with EGFR mutation in patients with subsolid nodules like stage I-II LUAD.

Characteristics

EGFR mutation

(n = 173)

EGFR wild-type

(n = 152)

P-values

Location

   

right upper lobe

56(32.4%)

66(43.4%)

 

right middle lobe

12(6.9%)

8(5.3%)

 

right lower lobe

34(19.7%)

20(13.2%)

 

left upper lobe

42(24.3%)

26(17.1%)

 

left lower lobe

29(16.8%)

32(21.1%)

0.098

Tumor size (cm)

1.60 ± 0.50

1.24 ± 0.41

<0.01

Category of nodule

   

pGGN

48(27.7%)

81(53.3%)

 

mGGN

125(72.3%)

71(46.7%)

<0.01

Lobulation

   

positive

90(52.0%)

59(38.8%)

 

negative

83(48.0%)

93(61.2%)

0.012

Spiculation

   

positive

49(28.3%)

38(25.0%)

 

negative

124(71.7%)

114(75.0%)

0.497

Vascular changes

   

positive

91(52.6%)

86(56.6%)

 

negative

82(47.4%)

66(43.4%)

0.470

Air-bronchogram

   

positive

81(46.8%)

54(35.5%)

 

negative

92(53.2%)

98(64.5%)

0.034

Bubblelike lucency

   

positive

98(56.6%)

63(41.4%)

 

negative

75(43.4%)

89(58.6%)

<0.01

Pleural retraction

   

positive

96(55.5%)

53(34.9%)

 

negative

77(44.5%)

99(65.1%)

0.010

Histopathologic subtype

   

precursor glandular lesions

5(2.9%)

6(3.9%)

 

adenocarcinomas

168(97.1%)

146(96.1%)

0.597

TLS

   

positive

76(43.9%)

92(68.4%)

 

negative

97(56.1%)

60(31.6%)

<0.01